Voltaren (Diclofenac) Patch Dosing
For diclofenac patches, apply one 180 mg patch once daily or twice daily to the painful area. 1
Standard Dosing Regimen
The recommended dosing for diclofenac patches is straightforward:
- Apply one 180 mg patch daily, or
- Apply one 180 mg patch twice daily (every 12 hours)
This dosing comes directly from NCCN cancer pain guidelines 1 and is supported by multiple clinical contexts including osteoarthritis 2 and actinic keratosis treatment 3.
Application Guidelines
Apply the patch directly to the painful site. The patch acts locally with minimal systemic absorption 1, making it particularly useful as a co-analgesic when combined with other pain medications including opioids, antidepressants, or anticonvulsants for complex pain syndromes 1.
Clinical Context
The diclofenac patch delivers therapeutic concentrations of medication to underlying tissue while limiting systemic exposure 4. Pain relief typically begins within 3 hours of application 4, with the medication first appearing in plasma at a mean of 4.5 hours (range 2-8 hours) 4. This demonstrates true local tissue action rather than systemic effect.
Systemic absorption is remarkably low - only about 6% compared to oral diclofenac formulations 5, with plasma concentrations 158 times lower than oral dosing 5. This translates to significantly fewer gastrointestinal and systemic side effects compared to oral NSAIDs 6.
Important Precautions
- Do not apply heat after patch application - the pharmacokinetics under this condition have not been tested 5
- Heat application before gel application has been studied and appears safe, but concurrent heat use with patches is not recommended 5
- Most common adverse events are application site reactions (pruritus, rash), occurring in approximately 7-8% of patients 7
Duration of Treatment
Treatment duration varies by indication:
- Acute injuries: typically 7-14 days or until pain resolution 7, 8
- Chronic conditions (e.g., osteoarthritis): may be used longer-term with appropriate monitoring 9
The patch formulation is particularly well-tolerated with low withdrawal rates and excellent patient-reported tolerability (80% rated as excellent or good) 7.